Anti-AKAP9 antibodies are used in the immunodetection of the protein A-kinase anchoring protein 9. In humans, the canonical protein has a reported length of 3907 amino acid residues and a mass of 453 kDa. Its subcellular localization is in the Golgi and cytoplasm. Up to 6 different isoforms have been reported for this protein. It is widely expressed across many tissue types. AKAP9 is reported to be a scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. The AKAP9 gene has been associated with the disease, Long QT syndrome. Synonyms for this target antigen include AKAP450, CG-NAP, HYPERION, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, and AKAP350. AKAP9 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of AKAP9 antibodies have been mentioned in research publications and have associated citations. ELISA, Western Blot, and Immunohistochemistry are common applications for these antibodies.